BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED (02487574) is a private limited company registered in DENHAM, incorporated in 1990. The company operates in the manufacture of basic pharmaceutical products sector. Our database holds 92 signals from 14 official sources covering this company's filings, appointments, and regulatory records. Risk assessment: 89/100 ("robust"), reflecting a strong compliance and financial profile.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is an active private company incorporated in 1990, based in Denham, focusing on the manufacture of basic pharmaceutical products.
Good data coverage from 14 sources. Risk score of 89 indicates a strong compliance profile.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is 1 of 2 manufacture of basic pharmaceutical products companies in DENHAM, out of 1,082 active companies in this sector nationally (1,326 including dissolved).
The 3 directors of BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED are connected to 10 other companies.
Of these, 2 (20%) are dissolved or failed.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is listed as the proprietor of 6 properties in the HM Land Registry.
Properties are located in North West, South East.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED has received 2 Innovate UK grants. This shows active participation in UK innovation programmes.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED pays invoices in an average of 50 days. 36% are paid within 30 days.
This company profile is built from 14 official data sources: Ch Officers, Companies House, Environment Agency, FCA Register, GLEIF, Gateway to Research, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, ICO, Innovate UK, Modern Slavery Registry, Payment Practices, WHOIS.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is an active private company incorporated in 1990, based in Denham, focusing on the manufacture of basic pharmaceutical products..
Current directors include , .
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is registered in DENHAM, United Kingdom.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED operates under SIC code 21100 — Manufacture of basic pharmaceutical products.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED has a risk score of 89 out of 100, classified as "Robust". This score is calculated from 92 data signals across 14 government sources.
The next accounts for BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED are due on 30 Sept 2026.
Yes, BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is listed as the proprietor of 6 properties in the HM Land Registry, located in North West, South East.
The dissolution rate for the manufacture of basic pharmaceutical products sector in the UK is 8.6%. The average company age in this sector is 14.5 years.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED was incorporated on 2 Apr 1990, making it 36 years old. The company remains active and in good standing.
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is classified under SIC code 21100 (Manufacture of basic pharmaceutical products). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 92 data signals from 14 official government sources for BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED.